WA
CBST

Whitebox Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Whitebox Advisors’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-42,500
Closed -$2.82M – 466
2014
Q3 		$2.82M Hold
42,500
– – 0.11% 170
2014
Q2 		$2.97M Hold
42,500
– – 0.12% 165
2014
Q1 		$3.11M Buy
+42,500
New +$3.17M 0.13% 126

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Whitebox Advisors's CBST Position: Q4 2014 in Review

Whitebox Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 42,500 shares — an estimated $2.82M sold.

Whitebox Advisors first reported a position in CBST in Q1 2014 and held it in 3 quarters. The position peaked at $3.11M in Q1 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Whitebox Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Whitebox Advisors sold 42,500 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $2.82M.
  • Whitebox Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q1 2014 and held it in 3 quarters.
  • Whitebox Advisors's CUBIST PHARMACEUTICALS INC position peaked at $3.11M in Q1 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Whitebox Advisors's 13F filing for Q4 2014, filed 12 Feb 2015.